ADROMEDA AS: årsregnskap 2024 vs 2023
Shrank 76% on revenue, weaker earnings
approved 2025-06-18; registry 2025-06-21; journal 2025 555826
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for ADROMEDA AS. Revenue 5 015 NOK → 1 215 NOK (-75.8%). Net result +918.0k NOK → +531.4k NOK. Equity -6.90m NOK → -5.36m NOK.
On the constructive side: equity strengthened; cash rose. Pressures included: revenue fell; operating result weakened; net result weakened.
Also worth watching: book investments changed. All figures are taken from the published annual accounts for ADROMEDA AS.
At a glance
Scorecard
What improved
-
↑
Equity strengthened
Book equity -6.90m NOK → -5.36m NOK (equity ratio -1744.9% → -213.0%). Calculated
-
↑
Cash rose
Bank deposits 213.5k NOK → 2.24m NOK (+947.5% YoY). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 5 015 NOK to 1 215 NOK (-75.8% YoY). Calculated
-
↓
Operating result weakened
Operating result -21.2k NOK → -26.8k NOK (op. margin -422.2% → -2204.5%). Calculated
-
↓
Net result weakened
Net result +918.0k NOK → +531.4k NOK (net margin 18305.6% → 43735.9%). Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 131.2k NOK → 231.2k NOK. Reported fact